Current Studies

Have you used prednisone recently? 

NCCR has multiple studies requiring the use of prednisone for an asthma worsening over the last 12 to 18 months. Please call Teresa at 919-881-0309.    

Asthma


Asthma study for subjects currently using Nucula or Fasenra as part of their asthma treatment

  • Ages 12 years old & Up 
  • Currently using a daily maintenance inhaler
  • Everyone receives active study medication
  • Lifetime Nonsmoker or nonsmoker for 6 months with limited smoking history
  • Willing to complete 15 visits over 15 months
  • Study related care and study medication at no cost
  • Compensation for qualified participants is up to $1710

Asthma


 Asthma study evaluating a new combination inhaler

  • Ages 12 – 80 years old
  • Currently using a daily maintenance inhaler
  • Everyone receives active study medication (No chance of Placebo)
  • Lifetime Nonsmoker or nonsmoker for 6 months with limited smoking history
  • Willing to complete 8 visits over 28 weeks
  • Study related care and study medication at no cost
  • Continue on your current inhaler
  • Compensation for qualified participants is $1500-$2300

Asthma


Asthma study evaluating a new Generic Albuterol

  • Ages 18 – 65 years old 
  • Currently using a low dose daily maintenance inhaler  ( Flovent, Arnuity, Pulmicort, QVAR or Asmanex)
  • Lifetime Nonsmokers or nonsmoker for 6 months with very limited smoking history
  • Willing to complete 7 visits over 6 weeks
  • Study related care and study medication at no cost
  • Compensation for qualified participants is up to $700

Asthma


 Asthma study evaluating a new combination inhaler

  • Ages 12 – 80 years old
  • Currently using a daily maintenance inhaler
  • Everyone receives active study medication (No chance of Placebo)
  • Lifetime Nonsmoker or nonsmoker for 6 months with limited smoking history
  • Willing to complete 15 visits over 28 – 52 weeks
  • Study related care and study medication at no cost
  • Compensation for qualified participants up to $1,000

Asthma


Adult asthma study evaluating a new “Add on medication” 

  • Ages 18 years old and Up
  • Lifetime Nonsmoker or nonsmoker for 6 months with limited smoking history
  • Willing to complete 10 visits over 34 weeks
  • Study related care and study medication at no cost
  • Compensation for qualified participants is up to $1225

Asthma


Adult asthma study evaluating a new “Add on” inhaler

  • Ages 18 – 75 years old
  • Lifetime Nonsmoker or nonsmoker for 6 months with limited smoking history
  • Study medication is an “Add On” inhaler
  • Participants will remain on their current maintenance inhaled steroid treatment
  • Willing to complete 11 visits over 30 weeks
  •  Study related care and study medication at no cost
  • Compensation for qualified participants is up to $1760

COPD


COPD study evaluating 2 FDA approved treatments:

Spiriva Dry Powder or Revefenacin by jet nebulizer

  • Ages 40 years old and up
  • Current or former smoker
  • Willing to complete 5 visits over approx. 13 weeks
  • Study related care and study medication at no cost
  • Compensation for qualified participants is up to $410

COPD


COPD study evaluating a new Generic Atrovent

  • Ages 40 years old and up
  • Current or former smoker
  • Willing to complete 4-5 visits over 25 – 55 days
  • Study related care and study medication at no cost
  • Compensation for qualified participants is up to $850

MIGRAINE HEADACHE


Migraine study evaluating a new investigational medicine for acute treatment of migraines. 

  • Ages 18 to 65 years 
  • Have had migraines for at least 1 year
  • Have 2 to 8 migraine attacks each month
  • Have less than 15 headache days each month
  • Study related care and study medication at no cost
  • Compensation for qualified participants is up to $300 (additional compensation for compliant diary assessments)

MIGRAINE HEADACHE


Migraine study to investigate the efficacy and safety of 2 FDA approved medications for acute treatment of migraines.  

  • Ages 18 to 65 years 
  • Have had migraines for at least 1 year with onset prior to age 50
  • Have an average of 2 migraine attacks per month over the past 3 months
  • Have an average of 4 to 14 migraine headache days per month over the past 3 months
  • Body Mass Index (BMI) <40kg/m2
  • Study related care and study medication at no cost
  • Compensation for qualified participants up to $840

 

Our office will be closed: Friday, January 21st , 2022 due to inclement weather.
We will re-open on Monday, January 24th 2022 at 8:30 am